Honeywell
Official SEC filings
Source: SEC EDGAR. Latest available cached filings; filing date is not the financial period end. Index checked: 2026-11-22 01:43 UTC.
| Form | Filed | Original document |
|---|---|---|
| 10-Q | 2026-10-22 | Read on SEC.gov |
| 8-K | 2026-10-22 | Read on SEC.gov |
| 8-K | 2026-08-19 | Read on SEC.gov |
| 10-Q | 2026-07-23 | Read on SEC.gov |
| 8-K | 2026-07-23 | Read on SEC.gov |
| 8-K | 2026-06-29 | Read on SEC.gov |
| 8-K | 2026-06-15 | Read on SEC.gov |
| 8-K | 2026-06-05 | Read on SEC.gov |
SEC annual financial snapshot
Standard US-GAAP facts in 10-K filings, USD. Income and cash flow cover the annual period; balance-sheet amounts are as of period end. These are not quarterly or TTM figures. Latest available filed values may include restatements; reporting periods can differ from other providers. Checked: 2026-11-22 05:51 UTC.
| Metric | USD | Basis | Period end | Filed | Source |
|---|---|---|---|---|---|
| Revenue | $37.44B | Annual | 2025-12-31 | 2026-02-17 | 10-K |
| Net income | $4.73B | Annual | 2025-12-31 | 2026-02-17 | 10-K |
| Operating cash flow | $6.41B | Annual | 2025-12-31 | 2026-02-17 | 10-K |
| Total assets | $73.68B | As of | 2025-12-31 | 2026-02-17 | 10-K |
| Stockholders’ equity | $13.90B | As of | 2025-12-31 | 2026-02-17 | 10-K |
| Cash and cash equivalents | $12.49B | As of | 2025-12-31 | 2026-02-17 | 10-K |
✦ Quant Financial Health how this is computed
- Altman Z-Score is 2.57, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
✦ Quant Revenue Concentration how this is computed
- Building Automation is the largest reported line at 40.45% of revenue, across 3 reported segments.
- No single line clears half of revenue; Process Automation and Technology is next at 37.22%, spreading the business across more than one real driver.
Revenue annual, last 8 years
Latest year +7.85% YoY
Margins
- Gross margin
- 36.93%
- Operating margin
- 17.54%
- Net margin
- 12.63%
Key ratios & quality
- Enterprise valuei
- 89.31B
- Altman Z-Scorei
- 2.57
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 41.80B | 36.71B | 32.64B | 34.39B | 35.47B | 33.01B | 34.72B | 37.44B |
| Gross profit | 12.76B | 12.37B | 10.47B | 12.33B | 13.12B | 12.37B | 13.36B | 13.83B |
| Selling & admin expenses | 6.05B | 5.52B | 4.77B | 4.80B | 5.21B | 4.89B | 5.24B | 5.45B |
| Research & development | -- | -- | -- | 1.33B | 1.48B | 1.38B | 1.45B | 1.81B |
| Operating profit | 6.71B | 6.85B | 5.70B | 6.20B | 6.43B | 6.11B | 6.67B | 6.57B |
| Pretax profit | 7.49B | 7.56B | 6.01B | 7.24B | 6.38B | 6.19B | 6.24B | 5.48B |
| Tax | 659.00M | 1.33B | 1.15B | 1.63B | 1.41B | 1.26B | 1.25B | 1.01B |
| Net profit | 6.83B | 6.23B | 4.87B | 5.61B | 4.97B | 5.67B | 5.74B | 4.77B |
| Basic EPS | 18 | 17 | 14 | 16 | 15 | 17 | 18 | 15 |
| Diluted EPS | 17.96 | 16.82 | 13.44 | 15.82 | 14.54 | 16.94 | 17.42 | 14.72 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Revenue | 9.32B | 4.93B | 22.74B | 9.14B | 9.72B | 4.99B |
| Gross profit | 3.66B | 1.77B | 8.05B | 3.54B | 3.65B | 2.02B |
| Selling & admin expenses | 1.36B | 1.09B | 2.08B | 1.31B | 1.34B | 1.04B |
| Research & development | 459.00M | 268.00M | 1.04B | 492.00M | 524.00M | 239.00M |
| Operating profit | 1.84B | 413.00M | 4.94B | 1.74B | 1.79B | 740.00M |
| Pretax profit | 1.63B | 1.11B | 3.45B | 886.00M | 7.53B | 986.00M |
| Tax | 244.00M | 153.00M | 581.00M | 91.00M | 1.58B | 60.00M |
| Net profit | 1.57B | 1.86B | -123.00M | 795.00M | 5.69B | 676.00M |
| Basic EPS | 5 | 6 | 1 | 3 | 18 | 2 |
| Diluted EPS | 4.90 | 5.71 | 0.92 | 2.58 | 17.83 | 2.08 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 24.36B | 24.30B | 28.18B | 25.37B | 24.98B | 23.50B | 27.91B | 30.39B |
| Cash & ST investments | 10.91B | 10.42B | 15.22B | 11.52B | 10.11B | 8.10B | 10.29B | 12.93B |
| Inventory | 4.33B | 4.42B | 4.49B | 5.14B | 5.54B | 6.18B | 5.88B | 6.16B |
| Total assets | 57.77B | 58.68B | 64.59B | 64.47B | 62.28B | 61.53B | 75.20B | 73.68B |
| Total current liabilities | 18.92B | 18.10B | 19.20B | 19.51B | 19.94B | 18.54B | 21.26B | 23.41B |
| Short-term debt | 6.46B | 5.06B | 6.23B | 5.53B | 4.64B | 4.08B | 5.77B | 7.61B |
| Long-term debt | 9.76B | 11.11B | 16.34B | 14.25B | 15.12B | 16.56B | 25.44B | 27.14B |
| Total liabilities | 39,408,000,000.00 | 39,966,000,000.00 | 46,789,000,000.00 | 45,221,000,000.00 | 44,949,000,000.00 | 45,084,000,000.00 | 56,035,000,000.00 | 58,651,000,000.00 |
| Total equity | 18.37B | 18.71B | 17.80B | 19.25B | 17.33B | 16.44B | 19.16B | 15.03B |
| Retained earnings | 33.98B | 37.69B | 39.91B | 42.83B | 45.09B | 47.98B | 50.84B | 50.96B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Total current assets | 27.97B | 30.75B | 30.39B | 30.59B | 28.08B | 14.32B |
| Cash & ST investments | 10.68B | 13.36B | 12.93B | 12.39B | 9.20B | 6.19B |
| Inventory | 7.01B | 7.12B | 6.16B | 6.37B | 6.40B | 2.06B |
| Total assets | 78.42B | 80.92B | 73.68B | 73.99B | 77.34B | 53.10B |
| Total current liabilities | 21.62B | 22.64B | 23.41B | 22.09B | 23.19B | 14.91B |
| Short-term debt | 6.35B | 6.95B | 7.61B | 7.73B | 7.76B | 6.21B |
| Long-term debt | 30.17B | 30.09B | 27.14B | 29.01B | 26.23B | 10.39B |
| Total liabilities | 61,765,000,000.00 | 63,163,000,000.00 | 58,651,000,000.00 | 59,321,000,000.00 | 58,487,000,000.00 | 30,444,000,000.00 |
| Total equity | 16.65B | 17.75B | 15.03B | 14.67B | 18.86B | 22.65B |
| Retained earnings | 52.40B | 53.50B | 50.96B | 51.03B | 55.96B | 58.76B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 6.43B | 6.90B | 6.21B | 6.04B | 5.27B | 5.34B | 6.10B | 6.41B |
| Depreciation & amortization | 1.12B | 1.09B | 1.00B | 1.22B | 1.20B | 1.00B | 1.15B | 1.39B |
| Free cash flow | 5.61B | 6.06B | 5.30B | 5.14B | 4.51B | 4.60B | 5.23B | 5.42B |
| Dividends paid | -2.27B | -2.44B | -2.59B | -2.63B | -2.72B | -2.86B | -2.90B | -2.98B |
| Stock buybacks / issuance | -3.73B | -3.90B | -3.32B | -3.15B | -3.88B | -3.52B | -1.12B | -3.57B |
| Ending cash balance | 9.29B | 9.07B | 14.28B | 10.96B | 9.63B | 7.93B | 10.57B | 12.49B |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.32B | 3.29B | 1.20B | -650.00M | 1.28B | 117.00M |
| Depreciation & amortization | 348.00M | 43.00M | 672.00M | 357.00M | 312.00M | 29.00M |
| Free cash flow | 1.09B | 3.33B | 593.00M | -873.00M | 961.00M | 286.00M |
| Dividends paid | -747.00M | -735.00M | -762.00M | -781.00M | -795.00M | -240.00M |
| Stock buybacks / issuance | -1.65B | -58.00M | -3.00M | -830.00M | 29.00M | 47.00M |
| Ending cash balance | 10.35B | 12.93B | 12.49B | 11.98B | 8.75B | 5.69B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 38.16 | 33.50 | 26.52 | 30.69 | 28.16 | 34.76 | 33.10 | 29.08 |
| ROA %i | 11.55 | 10.55 | 7.75 | 8.59 | 7.84 | 9.14 | 8.35 | 6.35 |
| ROIC %i | 19.85 | 17.90 | 13.12 | 14.33 | 13.56 | 16.11 | 14.07 | 11.01 |
| 5-year avg ROE %i | 24.77 | 26.64 | 26.64 | 27.67 | 31.58 | 30.73 | 30.65 | 31.16 |
| EBIT margin %i | 18.79 | 21.56 | 19.52 | 22.03 | 19.15 | 21.61 | 21.48 | 18.21 |
| FCF / sales %i | 13.41 | 16.50 | 16.25 | 14.95 | 12.71 | 11.73 | 12.81 | 14.48 |
| Current ratioi | 1.29 | 1.34 | 1.47 | 1.30 | 1.25 | 1.27 | 1.31 | 1.30 |
| Quick ratioi | 0.97 | 0.99 | 1.15 | 0.94 | 0.88 | 0.84 | 0.83 | 0.88 |
| Debt / assetsi | 28.07 | 28.47 | 35.94 | 32.00 | 32.98 | 35.00 | 42.66 | 48.27 |
| LT debt / equityi | 53.66 | 62.96 | 96.77 | 81.32 | 95.21 | 110.11 | 141.27 | 201.02 |
| Interest coveragei | 21.40 | 22.17 | 17.75 | 22.09 | 16.41 | 10.36 | 7.82 | 5.07 |
| Revenue CAGR (3Y) %i | 2.71 | -2.25 | -6.97 | -6.30 | -1.14 | 0.38 | 0.31 | 1.82 |
| Net income CAGR (3Y) %i | 12.37 | 8.48 | 45.70 | -6.43 | -6.84 | 5.79 | 0.97 | -1.62 |
| FCF CAGR (3Y) %i | 8.03 | 11.22 | 2.42 | -2.83 | -9.38 | -4.63 | 0.54 | 6.35 |
| Line item | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 | 2026-09 |
|---|---|---|---|---|---|---|
| ROE %i | 34.60 | 35.85 | 29.08 | 26.41 | 47.43 | 35.98 |
| ROA %i | 7.74 | 7.94 | 6.35 | 5.50 | 10.55 | 10.52 |
| ROIC %i | 13.09 | 13.47 | 11.01 | 9.91 | 17.28 | 16.76 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 20.82 | 21.59 | 18.21 | 16.23 | 31.66 | 33.24 |
| FCF / sales %i | 12.42 | 15.16 | 14.48 | 11.00 | 10.54 | 2.56 |
| Current ratioi | 1.29 | 1.36 | 1.30 | 1.39 | 1.21 | 0.96 |
| Quick ratioi | 0.90 | 0.98 | 0.88 | 0.93 | 0.76 | 0.76 |
| Debt / assetsi | 46.56 | 45.77 | 48.27 | 49.66 | 43.94 | 31.25 |
| LT debt / equityi | 187.43 | 179.31 | 201.02 | 213.47 | 141.49 | 46.33 |
| Interest coveragei | 6.92 | 6.96 | 5.07 | 4.32 | 8.31 | 10.39 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Quote time 2026-11-20 19:56:53 · For reference only, not investment advice and not tailored to your situation.
Honeywell discussion 0 comments